Mitochondria-first Hypothesis

Within this model, impaired electron transport can reduce ATP production while increasing reactive oxygen species, creating a combined energy and oxidative burden. Defective mitophagy, the process linked to mitochondrial quality control in the hypothesis, may allow damaged mitochondria to persist. Together, these changes can disturb neuronal energy balance and help drive later protein aggregation, inflammation, and cell death.

Selective neuronal vulnerability is examined by asking why mitochondrial disturbances affect some neurons more severely than others. The framework connects this question to differences in energy balance and mitochondrial quality control, rather than treating neuronal injury as an isolated downstream event. This emphasis helps researchers investigate whether impaired mitochondrial maintenance precedes the cellular changes associated with neurodegenerative disease.

The mitochondria-first hypothesis differs from a model in which mitochondrial impairment appears only after another disease process has already begun. Its key test is temporal and causal: researchers ask whether defects in electron transport, ATP production, reactive oxygen species, or mitophagy can initiate subsequent protein aggregation, inflammation, and cell death. That comparison shapes how disease pathways are interpreted.

These approaches examine the proposed sequence from mitochondrial dysfunction to cellular damage using complementary evidence. Genetic experiments can address factors associated with mitochondrial quality control, biochemical analyses can assess electron transport, ATP production, or reactive oxygen species, and live-cell methods can follow changes over time. Combining them helps distinguish an initiating mitochondrial defect from a later consequence.

Support would come from evidence that mitochondrial abnormalities occur early and are linked to later disruption of neuronal energy balance, protein aggregation, inflammation, or cell death. Particularly informative results would connect defective electron transport, reduced ATP production, excess reactive oxygen species, or impaired mitophagy with those downstream outcomes. The framework therefore guides interpretation of timing and causal relationships.

In Parkinson’s disease research, the framework links mitochondrial dysfunction and quality control to selective neuronal vulnerability. It encourages studies that ask whether restoring mitochondrial function can interrupt the cascade leading to cellular injury, rather than addressing only downstream protein aggregation or inflammation. More broadly, the same reasoning may help investigate other neurodegenerative disorders and evaluate treatment strategies.